In the study by Li et al. [43], overexpression of cyclin D2 (CCND2) and activation of the Wnt pathway in the activated B-cell (ABC) subtype of DLBCL were validated by bioinformatics and experiments. Here, CCND2 is linked to diffuse large B-cell lymphoma.